Skip to content

Clinical trials

Recruiting Prostatic Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Status: Recruiting Country / region: China Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20171
20191
20204
20213
20222
202315
202435
202537
202636

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting136

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University First Hospital10
First Affiliated Hospital of Fujian Medical University7
Jiangsu HengRui Medicine Co., Ltd.6
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School6
AstraZeneca5
RenJi Hospital5
Xijing Hospital5
Anhui Provincial Hospital4
Fudan University4
The First Affiliated Hospital with Nanjing Medical University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms136
Disease15
Breast Neoplasms10
Ovarian Neoplasms10
Adenocarcinoma7
Neoplasm Metastasis7
Urinary Bladder Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Colorectal Neoplasms6
Esophageal Neoplasms6

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.